KardiaTec
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1506 Willow Oak Pond Ln, Charlotte, Nort...Website
www.kardiatec.comRevenue
<$5 MillionIndustry
About KardiaTec
KardiaTec Org Chart
Is KardiaTec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at KardiaTec
Check out if KardiaTec is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
KardiaTec, which may be a good buyer, showed buying intent in Masked Content Topic
Check if KardiaTec has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on KardiaTec recently announced quarterly report
Click to see if KardiaTec had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when KardiaTec launches new products
Funding: Get notified immidiatlly once KardiaTec has new funding data
Recommended Actions
Reach out to Masked Content who joined KardiaTec as Masked Content
Find more new buyers
Compare Similar Companies to KardiaTec
Compare insights from companies similar to KardiaTec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
KardiaTec is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
KardiaTec is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about KardiaTec.
KardiaTec Tech Stack
A closer look at the technologies used by KardiaTec
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KardiaTec
Kardiatec is focused on the development and commercialization of the PULVAD, designed for patients suffering from end-stage heart failure.... Read More